Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Hims & Hers Health, Inc. (HIMS)

7.75   0.16 (2.11%) 01-27 16:00
Open: 7.54 Pre. Close: 7.59
High: 7.79 Low: 7.405
Volume: 1,338,019 Market Cap: 1,610(M)

Technical analysis

as of: 2023-01-27 4:45:09 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 9.3     One year: 10.87
Support: Support1: 6.75    Support2: 6.01
Resistance: Resistance1: 7.96    Resistance2: 9.3
Pivot: 7.26
Moving Average: MA(5): 7.6     MA(20): 7.03
MA(100): 5.98     MA(250): 5.37
MACD: MACD(12,26): 0.3     Signal(9): 0.2
Stochastic oscillator: %K(14,3): 80.6     %D(3): 79.5
RSI: RSI(14): 63.6
52-week: High: 7.96  Low: 2.72
Average Vol(K): 3-Month: 1,740 (K)  10-Days: 1,486 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ HIMS ] has closed below upper band by 25.2%. Bollinger Bands are 29.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.8 - 7.83 7.83 - 7.85
Low: 7.33 - 7.36 7.36 - 7.39
Close: 7.69 - 7.75 7.75 - 7.8

Company Description

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.

Headline News

Fri, 27 Jan 2023
The 6 Best Over-the-Counter Hair Loss Treatment Options Available ... - ABC Action News Tampa Bay

Wed, 25 Jan 2023
Hims & Hers: Profitability Pulled Forward (NYSE:HIMS) - Seeking Alpha

Wed, 25 Jan 2023
Hims & Hers unveils new shampoo, conditioner products - Retail Dive

Wed, 18 Jan 2023
Hims & Hers Launches New Line of Volumizing Shampoos and ... - Business Wire

Wed, 18 Jan 2023
Hims & Hers Health: Buy Into The Strong Growth Momentum (NYSE ... - Seeking Alpha

Tue, 17 Jan 2023
Strs Ohio Sells 29100 Shares of Hims & Hers Health, Inc. (NYSE ... - MarketBeat

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Consumer Defensive
Industry:  Household & Personal Products
Shares Out. 196 (M)
Shares Float 128 (M)
% Held by Insiders 21.9 (%)
% Held by Institutions 55.6 (%)
Shares Short 13,930 (K)
Shares Short P.Month 13,640 (K)

Stock Financials

EPS -0.44
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.74
Profit Margin (%) -22.3
Operating Margin (%) -23.9
Return on Assets (ttm) -15.3
Return on Equity (ttm) -27.2
Qtrly Rev. Growth 87
Gross Profit (p.s.) 1.04
Sales Per Share 1.91
EBITDA (p.s.) -0.43
Qtrly Earnings Growth 0
Operating Cash Flow -45 (M)
Levered Free Cash Flow -1 (M)

Stock Valuations

PE Ratio -17.62
PEG Ratio -0.3
Price to Book value 4.45
Price to Sales 4.05
Price to Cash Flow -33.79

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.